Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Hi-Tech Pharmaceuticals Announces Fastin Rapid Release® Clinical Study Results

Hi-Tech Pharmaceuticals, Inc.

News provided by

Hi-Tech Pharmaceuticals, Inc.

Mar 31, 2015, 03:51 ET

Share this article

Share toX

Share this article

Share toX

NORCROSS, Ga., March 31, 2015 /PRNewswire/ -- Fastin Rapid Release® is a quantum leap in the field of weight loss backed by two clinical studies -- one showed an increase in the metabolism by 22% in 45 minutes*, and the second study showed Fastin Rapid Release® users lost 208% more weight and 385% more fat than placebo**. The results seen with Fastin Rapid Release® were compared by Hi-Tech Researchers to previous studies on Ephedrine -- the Gold Standard for OTC diet aids. The findings were amazing as Fastin Rapid Release® was found to be 66% stronger than 30mg Ephedrine and 152% stronger than 10mg Ephedrine.

Fastin Rapid Release® has a multi-million dollar advertising campaign that has been launched as it was initially sold exclusively at the Nationwide Retailer Rite Aid. Hi-Tech distributors have now begun to take on the product and other major chains are in the process of placing orders. Fastin Rapid Release® is a state-of the-art weight loss aid manufactured by Hi-Tech Pharmaceuticals - where science never stands still™!  

Fastin Rapid Release® is a new weight and fat loss product from Hi-Tech Pharmaceuticals, Inc. ("Hi-Tech") that is unlike any diet & energy aid to ever be released on the supplement market! Fastin Rapid Release® is made with Explotab® technology for an immediate burst of the active ingredients, providing rapid onset of  explosive energy and thermogenesis. Fastin Rapid Release® incorporates an  advanced delivery system to put the ingredient powerhouse into action. Hi-Tech chose to use Explotab®, which is remarkably effective for rapid disintegration and enhanced dissolution. The mechanism by which this action takes place involves accelerated absorption of water leading to an enormous increase in the volume of granules. This results in rapid and uniform tablet disintegration leading to increases in the metabolism by 22% in 45 minutes; study analyses revealed no significant differences between conditions at baseline in values of VO2, VE, or RER. Results indicated that VO2 change scores for FAS were significantly greater at all time points following ingestion (+22.1%, +18.9%, +15.9%, +12.6%, +8.4%) compared with PL (0.4%, -1.7%, -2.3%, -1.1%, 0.5%) and compared with CAF ( +6.3%, +6.5%, +7.1%, +4.2 %, +3.6%) (p's < 0.05). Similar response patterns were observed for VE as VO2 with FAS: (+26.6, +22.9%, +23.3%, +18.7%, +9.0%), CAF (+6.3%, +9.4%, +7.8%, +7.6%, +9.3%) and PL (-1.3%, -2.5%, -1.9%, -3.6%, +3.1%). The FAS VE change scores were significantly greater than CAF and PL at 45 min, 90min and 3 hrs (p<0.05). The RER change scores with PL and CAF were within 2% of baseline values across the six hours of testing. In contrast, FAS produced a pattern of declining values of RER over time to 9% and 11% below baseline at 4½ hrs and 6 hrs post ingestion, respectively, which were significantly less than CAF and PL. 

"The nationwide launch of Fastin Rapid Release® is an important development for men and women who struggle with being overweight with and need help with weight management beyond diet and exercise," said Jared Wheat, Hi-Tech's President and Chief Executive Officer. "We thank our entire team and the people who participated in our clinical trial programs for making this achievement possible." Hi-Tech expects to sell a lot of Fastin Rapid Release® considering that more than a third of U.S. adults, 78.6 million, are overweight, according the federal Centers for Disease Control and Prevention. 

"The ideal candidate for a diet pill is to help people who are overweight is someone who uses the Fastin Rapid Release® as a tool, along with diet and exercise," says Wheat.

Hi-Tech will manufacture and supply the finished commercial product from its FDA Registered Drug facility in Pennsylvania. Very few dietary supplement companies have a facility that is a FDA-Registered facility for Pharmaceuticals. Hi-Tech has (5) US based facilities totaling over 400,000 square feet, which is among the largest in our industry.  

Fastin Rapid Release® is a revolutionary stimulant, fat loss aid, and helps people lose weight and feel great, as shown in the change in mean total body weight of the Fastin-RR group (-8.0 +/= 6.5 lbs) was significantly greater than the change in body weight observed in the Placebo group (-2.6 +/= 4.8) and in the Caffeine group (-3.0 +/= 5.5) (p's < 0.05), and in The decrease in body fat weight observed in the Fastin-RR group (-6.3 +/= 7.3 lbs) was statistically greater than the body fat weight loss in the Placebo group (-1.3 +/= 6.7 lbs) (p < 0.05).  Fastin Rapid Release® works by mimicking the effects of our endogenous catecholamines such as epinephrine, norepinephrine and dopamine. The principal mechanism of its action relies on its indirect stimulation of the adrenergic receptor system, which is part of the sympathetic nervous system (SNS), by increasing the activity of noradrenaline at the post-synaptic alpha- and beta-receptors. Fastin Rapid Release® has indirect sympathomimetic effects and due to its ability to cross the blood brain barrier, it is a CNS stimulant similar to ephedrine and other stimulants as it releases noradrenaline and dopamine. This helps you feel like doing more activities resulting in additional weight being lost due to exercise combined with Fastin Rapid Release®.

Fastin Rapid Release® users saw an Incredible 16.6 % increase in Resting Energy Expenditure (Metabolism) over the first 3 hours with an increase of over 14.5% in Energy Uptake over the entire 6+ hours! These findings also indicate that Fastin Rapid Release® produced a substantial shift in energy substrate utilization with significantly greater levels of fat oxidation.

According to Jared Wheat, "Fastin Rapid Release® really is the pre-eminent diet aid on the market right now because unlike most of the weight loss supplements on the market, it actually has two product-specific studies that provide evidence of efficacy. One study was conducted on Fastin Rapid Release® and its effects on the metabolic rate***. The second study was an 8 week weight loss and fat loss study that showed it caused people to lose 208% more weight and 385% more fat than placebo! It is a product dieters can trust to help them achieve their weight loss goals." †

†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to treat, cure, diagnose, or prevent any disease. This product should not be used in place of or as a substitute for recommendations by your healthcare professional. WARNING: this product can raise blood pressure and interfere with other drugs you may be taking. Talk to your doctor about this product.

About Hi-Tech: 
Hi-Tech Pharmaceuticals, Inc. is a leading global healthcare supplier that develops, manufactures and distributes dietary supplements, over-the-counter (OTC) and prescription pharmaceuticals, beverages, bulk dietary raw materials, and consumer products. Hi-Tech Pharmaceuticals is an enormously successful company that creates, manufactures and sells high-quality herbal products sold by the large, major retailers across the United States. These retailers include: GNC, Rite Aid, Vitamin Shoppe, NBTY, Kroger, Albertson's, CVS, Kmart, Hannaford, Cardinal Health, Mckesson Corporation, AmerisourceBergen, Harmon Stores, Fred Meyer, Osco Drugs, Supervalu, Roundy's, Sav-On Drugs, Meijer, Fruth Pharmacy, Kinney Drug, Kinray, A&P, Stop & Shop, Giant Eagle, HEB, Winn Dixie, Ingles, Food Lion, Harris Teeter, Bed Bath & Beyond, Amazon.com, and over 5,000 health food retailers and adult novelty stores, as well as in more than 80,000 convenience stores throughout the United States. Hi-Tech owns the brand names Hi-Tech Pharmaceuticals, Advanced Performance Supplements (APS), Nature's Essentials, and ALR Industries.

Hi-Tech Pharmaceuticals and its CEO — Jared Wheat's — Acquisition of Nittany Pharmaceuticals in late 2012 immediately doubled our solid dose and powder square footage. The former Nittany facility is a 130,000 sq. ft. modern facility located in central Pennsylvania, nestled in the scenic Big Valley 30 miles east of State College and 60 miles northwest of Harrisburg, Nittany was a full-service contract manufacturer that enjoyed continuous growth over the past 26 years in the nutrition and pharmaceutical industry. The 130,000 sq. ft. State-of-the art FDA registered facility follows strict Good Manufacturing Practices (cGMP). This facility also has a 10,000 sq. ft. science center which includes new state-of-the-art formulation development and QC laboratories along with a pilot scale manufacturing operation. The name was changed for that facility to Hi-Tech Nutraceuticals, LLC.

 Hi-Tech is one of the world's leading generics and branded pharmaceutical companies, providing products to customers throughout the world. The company maintains one of the industry's broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. Hi-Tech has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service. The company ranks among the top dietary  supplement companies in several markets around the world and has among the largest capacity of dietary supplements or generic drugs of any U.S.-based manufacturers.

CONTACT: Brandon Schopp, 888-855-7919

* http://origin-qps.onstreammedia.com/origin/multivu_archive/ENR/195774-JISSN_abstract_2013-Data012615.pdf

** http://origin-qps.onstreammedia.com/origin/multivu_archive/ENR/195775-JISSN_abstract_2014-Data012615.pdf 

*** http://www.jissn.com/content/10/S1/P11

Logo - http://photos.prnewswire.com/prnh/20150331/195758LOGO 

  

SOURCE Hi-Tech Pharmaceuticals, Inc.

Related Links

https://www.hitechpharma.com/index.htm

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.